Last Chance Recombinant Ebov (subtype Sudan, Strain Gulu) Vp40 / Matrix Protein Vp40 Protein (his Tag) Perfect For Gifting [CoRNh3eY]

Recombinant EBOV VP40 Protein (His Tag)

Our Last Chance Recombinant Ebov (subtype Sudan, Strain Gulu) Vp40 / Matrix Protein Vp40 Protein (his Tag) Perfect For Gifting [CoRNh3eY] is a high-quality recombinant protein derived from the Ebola virus. This protein is expressed in E. coli and is tagged with a His tag for easy purification and detection. With a purity of over 80% as determined by reducing SDS-PAGE, this protein is ideal for a variety of research applications, including structural studies, immunogenicity, and drug discovery.

• High Purity: Over 80% purity as determined by reducing SDS-PAGE.
• Expression Host: E. coli, ensuring efficient expression and purification.
• Tag: N-His tag for easy purification and detection.

Product Properties and Specifications

This recombinant protein is designed to provide researchers with a reliable and consistent source of EBOV VP40 protein. The protein sequence covers Val31-Lys326 and has a calculated molecular weight of 34.5 kDa. The protein is lyophilized from a sterile 50 mM Tris, 500 mM NaCl buffer, with 5% - 8% trehalose, mannitol, and 0.01% Tween 80 added as protectants before lyophilization. This ensures the stability and integrity of the protein during storage and reconstitution.

• Sequence: Val31-Lys326
• Accession: YP_138522.1
• Calculated Molecular Weight: 34.5 kDa

Practical Uses and Benefits

The Recombinant EBOV VP40 Protein (His Tag) is a versatile tool for various research applications. It can be used to study the structure and function of the Ebola virus, develop diagnostic tests, and investigate potential therapeutic agents. This protein is also suitable for use in immunogenicity studies, where it can be used to elicit an immune response in animals or humans.

• Research Applications: Structural studies, immunogenicity, and drug discovery.
• Target Audience: Researchers in virology, immunology, and infectious diseases.